SAN FRANCISCO -- In the hours after the Food and Drug Administration gave the go-ahead to Calgene to market its Flavr Savr tomato, the general feeling in the food industry about the future of the new bioengineered tomato seemed to be "wait and see." Industry leaders contacted by SN last Wednesday were reluctant to express even the ubiquitous "cautious optimism" for the future of the Flavr Savr. They said the future success or failure of the tomato, the nation's first genetically engineered ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.